Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Zolpidem Metabolite I

Major metabolite of zolpidem
 
BML-J136-0001 1 mg 319.00 USD
 
BML-J136-0005 5 mg 1,112.00 USD
Do you need bulk/larger quantities?
 
Zolpidem Metabolite I is the major metabolite of zolpidem. Zolpidem is a non-benzodiazepine compound that acts as an agonist to the GABA-Aγ1 subunit, which has been shown to treat insomia. Intake of zolpidem can be detected by quantification of the metabolites produced. Zolpidem metabolite I shows two absorption peaks in methanol. It emits blue fluorescence upon exiting at 303 nm in water (λem= 373 nm).

Product Specification

Alternative Name:4-[3-[2-(Dimethylamino)-2-oxoethyl]-6-methylimidazo[1,2-a]pyridin-2-yl] benzoic acid, Zolpidem carboxylic acid
 
Formula:C19H19N3O3
 
MW:337.37
 
CAS:109461-65-6
 
Absorbance maximum:247nm and 303nm
 
Purity:≥98% (HPLC)
 
Identity:Determined by MS and 1H-NMR.
 
Appearance:Off-white solid.
 
Solubility:Soluble in methanol, DMF and DMSO. Slightly soluble in water and ethyl acetate.
 
Shipping:Shipped on Dry Ice
 
Long Term Storage:-20°C
 
Handling:Hygroscopic. Protect from moisture. Keep cool and dry.
 
BML-J136 structure
Please mouse over
BML-J136 structure

Product Literature References

A Simple and Rapid Method for the Identification of Zolpidem Carboxylic Acid in Urine: J.H. Lewis & J.H. Vine; J. Anal. Toxicol. 31, 195 (2007), Abstract; Full Text

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
GABA receptor
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Brochures
Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,